Literature DB >> 25383716

Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma.

Honghua Hu1, Anita Jacombs, Karen Vickery, Steven L Merten, David G Pennington, Anand K Deva.   

Abstract

BACKGROUND: Biofilm infection of breast implants significantly potentiates capsular contracture. This study investigated whether chronic biofilm infection could promote T-cell hyperplasia.
METHODS: In the pig study, 12 textured and 12 smooth implants were inserted into three adult pigs. Implants were left in situ for a mean period of 8.75 months. In the human study, 57 capsules from patients with Baker grade IV contracture were collected prospectively over a 4-year period. Biofilm and surrounding lymphocytes were analyzed using culture, nucleic acid, and visualization techniques.
RESULTS: In the pig study, all samples were positive for bacterial biofilm. There was a significant correlation between the bacterial numbers and grade of capsular contracture (p = 0.04). Quantitative real-time polymerase chain reaction showed that all lymphocytes were significantly more numerous on textured compared with smooth implants (p < 0.001). T cells accounted for the majority of the lymphocytic infiltrate. Imaging confirmed the presence of activated lymphocytes. In the human study, all capsules were positive for biofilm. Analysis of lymphocyte numbers showed a T-cell predominance (p < 0.001). There was a significant linear correlation between the number of T and B cells and the number of detected bacteria (p < 0.001). Subset analysis showed a significantly higher number of bacteria for polyurethane implants (p < 0.005).
CONCLUSIONS: Chronic biofilm infection around breast prostheses produces an increased T-cell response both in the pig and in humans. A possible link between bacterial biofilm and T-cell hyperplasia is significant in light of breast implant-associated anaplastic large-cell lymphoma. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, V.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25383716     DOI: 10.1097/PRS.0000000000000886

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  44 in total

Review 1.  Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management.

Authors:  Tessa L St Cyr; Barbara A Pockaj; Donald W Northfelt; Fiona E Craig; Mark W Clemens; Raman C Mahabir
Journal:  Plast Surg (Oakv)       Date:  2020-05-21       Impact factor: 0.947

Review 2.  How to prevent complications in breast augmentation.

Authors:  Maurizio Bruno Nava; Alberto Rancati; Claudio Angrigiani; Giuseppe Catanuto; Nicola Rocco
Journal:  Gland Surg       Date:  2017-04

3.  Breast Implant Texturization Does Not Affect the Crosstalk Between MSC and ALCL Cells.

Authors:  Monia Orciani; Miriam Caffarini; Matteo Torresetti; Anna Campanati; Piercamillo Parodi; Giovanni Di Benedetto; Roberto Di Primio
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

4.  A Formidable Foe Is Sabotaging Your Results: What You Should Know about Biofilms and Wound Healing.

Authors:  Jenny C Barker; Ibrahim Khansa; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2017-05       Impact factor: 4.730

5.  Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

Authors:  Piers Blombery; Ella R Thompson; Kate Jones; Gisela Mir Arnau; Stephen Lade; John F Markham; Jason Li; Anand Deva; Ricky W Johnstone; Amit Khot; H Miles Prince; David Westerman
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

Review 6.  Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules.

Authors:  Mark W Clemens; Maurizio Bruno Nava; Nicola Rocco; Roberto N Miranda
Journal:  Gland Surg       Date:  2017-04

Review 7.  Advising patients about breast implant associated anaplastic large cell lymphoma.

Authors:  Christopher S Parham; Summer E Hanson; Charles E Butler; M Bradley Calobrace; Raylene Hollrah; Terri Macgregor; Mark W Clemens
Journal:  Gland Surg       Date:  2021-01

8.  Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Authors:  C Laurent; A Delas; P Gaulard; C Haioun; A Moreau; L Xerri; A Traverse-Glehen; T Rousset; I Quintin-Roue; T Petrella; J F Emile; N Amara; P Rochaix; M P Chenard-Neu; A M Tasei; E Menet; H Chomarat; V Costes; L Andrac-Meyer; J F Michiels; C Chassagne-Clement; L de Leval; P Brousset; G Delsol; L Lamant
Journal:  Ann Oncol       Date:  2015-11-23       Impact factor: 32.976

9.  ALK-negative anaplastic large cell lymphoma arising in the thrombus of an aortic prosthesis preceeded by clonally related lymphomatoid papulosis.

Authors:  Thomas Menter; Veronika Ballova; Clemens Caspar; Thomas Wolff; Benjamin Kasenda; Gad Singer; Darius Juskevicius; Alexandar Tzankov; Stefan Dirnhofer
Journal:  Virchows Arch       Date:  2019-01-26       Impact factor: 4.064

Review 10.  Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  P Rastogi; A K Deva; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.